ClinicalTrials.gg
Drug

Glatiramer clinical trials

Also written Copaxone.

studies test it
39
open now
0
in phase 3
15
first study started
1991

How each study uses glatiramer is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Approvals

The first approval found in each region, with its record

United States
20 Dec 1996 · COPAXONE · NDA 020622 (FDA, Drugs@FDA)
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Glatiramer Acetate
21
glatiramer acetate 20 mg
3
Glatiramer Acetate (Copaxone®)
2

Brand

Copaxone
20

Development codes

BCD-063
1

Studies by the year they started

39 studies that test it; most in 2006 (5)

Studies that test glatiramer, by start year
YearStudies
19911
19941
20034
20043
20052
20065
20073
20081
20092
20105
20111
20121
20133
20141
20151
20172
20192
20211

By phase

A phase 1/2 study counts in both.

Phase 1
3
Phase 2
12
Phase 3
15
Phase 4
9
No phase
2

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 21 · Other 18

Teva Branded Pharmaceutical Products R&D, Inc. (12) · Teva Neuroscience, Inc. (2) · Sanofi (2) · Sheba Medical Center (2) · The Cleveland Clinic (1) · University of Kansas Medical Center (1) · Hadassah Medical Organization (1) · Teva Pharmaceutical Industries, Ltd. (1)

Often tested with

Tested in the same studies.

Interferon beta-1a (3) · Natalizumab (2) · Methylprednisolone (2) · Interferon beta-1b (1) · Rituximab (1) · Teriflunomide (1) · Acetylcysteine (1) · Alemtuzumab (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 1

Studies that test glatiramer.

Studies

Open first, then newest update. How each study uses glatiramer is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 39

See all 39 studies that test glatiramer →

Given beside what is tested · 6 — glatiramer is usual care or a partner of the new treatment
As the comparator · 10 — what is tested is compared with glatiramer

Codes

What other systems call glatiramer · ClinicalTrials.gg INT006532

  • MeSH (NLM) D000068717Glatiramer AcetateConfirmed ClinicalTrials.gov, NLM
  • UNII (FDA) U782C039QPGLATIRAMERConfirmed FDA, NLM
  • RxNorm 214582One source FDA
  • NCI Thesaurus C87680GlatiramerOne source FDA

Also registered as glatiramer acetate (UNII 5M691HL4BO · RxNorm 84375).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.